West Family Investments Inc. Acquires 2,265 Shares of Haleon plc (NYSE:HLN)

West Family Investments Inc. grew its holdings in shares of Haleon plc (NYSE:HLN) by 16.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 15,746 shares of the company’s stock after acquiring an additional 2,265 shares during the period. West Family Investments Inc.’s holdings in Haleon were worth $150,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Sierra Ocean LLC bought a new position in Haleon during the 4th quarter worth $26,000. Versant Capital Management Inc increased its stake in shares of Haleon by 2,029.1% in the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after buying an additional 3,348 shares during the period. Geneos Wealth Management Inc. bought a new position in shares of Haleon during the fourth quarter worth about $35,000. Toronto Dominion Bank lifted its stake in shares of Haleon by 3,470.0% in the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after acquiring an additional 3,470 shares during the period. Finally, Spire Wealth Management acquired a new position in shares of Haleon in the fourth quarter worth approximately $39,000. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Up 0.5 %

Haleon stock opened at $10.45 on Friday. The company has a market capitalization of $47.29 billion, a PE ratio of 30.72, a PEG ratio of 2.82 and a beta of 0.25. Haleon plc has a 12-month low of $7.89 and a 12-month high of $10.80. The firm’s fifty day moving average is $9.66 and its 200 day moving average is $9.86. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The firm had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. As a group, sell-side analysts predict that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The company also recently disclosed a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be paid a $0.1166 dividend. This represents a yield of 1.6%. The ex-dividend date is Friday, April 25th. This is a boost from Haleon’s previous — dividend of $0.05. Haleon’s dividend payout ratio (DPR) is 58.97%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on HLN. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. HSBC reaffirmed a “hold” rating on shares of Haleon in a research report on Wednesday. Finally, Hsbc Global Res lowered Haleon from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Five research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Haleon presently has an average rating of “Moderate Buy” and an average price target of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.